Covetrus Inc
F:2NJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zero2ipo Holdings Inc.
HKEX:1945
|
CN |
|
Cuckoo Holdings Co Ltd
KRX:192400
|
KR |
|
F
|
Fidelity National Information Services Inc
DUS:ZGY
|
US |
|
E
|
Eli Lilly and Co
XETRA:LLY
|
US |
|
Tabuk Agricultural Development Co SJSC
SAU:6040
|
SA |
|
Broccoli Co Ltd
TSE:2706
|
JP |
|
Nissan Shatai Co Ltd
TSE:7222
|
JP |
|
D
|
Dida Inc
HKEX:2559
|
CN |
|
Tohokushinsha Film Corp
TSE:2329
|
JP |
|
Rli Corp
NYSE:RLI
|
US |
|
Y
|
Yoong Onn Corporation Bhd
KLSE:YOCB
|
MY |
|
Wallenstam AB
STO:WALL B
|
SE |
|
P
|
Prysmian SpA
OTC:PRYMY
|
IT |
|
iDreamSky Technology Holdings Ltd
HKEX:1119
|
CN |
|
K
|
KCP Sugar and Industries Corp Ltd
NSE:KCPSUGIND
|
IN |
Covetrus Inc
Total Current Liabilities
Covetrus Inc
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Covetrus Inc
F:2NJ
|
Total Current Liabilities
$20.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
|
Cardinal Health Inc
NYSE:CAH
|
Total Current Liabilities
$43.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
Henry Schein Inc
NASDAQ:HSIC
|
Total Current Liabilities
$3.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
|
Patterson Companies Inc
NASDAQ:PDCO
|
Total Current Liabilities
$1.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
|
Mckesson Corp
NYSE:MCK
|
Total Current Liabilities
$68.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
|
Cencora Inc
NYSE:COR
|
Total Current Liabilities
$59.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
Covetrus Inc
Glance View
Nestled in the heart of the animal health industry, Covetrus Inc. emerged as a formidable force, blending technological expertise with deep-rooted veterinary knowledge. Created in 2019 through the merger of Henry Schein Animal Health and Vets First Choice, this company has swiftly positioned itself as an essential partner for veterinary practitioners. Covetrus provides a comprehensive suite of services designed to streamline operations for veterinary clinics, ranging from practice management software to inventory management systems. The core of their operation focuses on enhancing clinic efficiency and improving patient outcomes, driven by digital innovation that connects clinics effortlessly with critical pharmaceuticals, pet foods, and other essential products. Covetrus's business model thrives on a multi-pronged approach. Revenue streams flow widely from the robust sales of prescription and non-prescription medications, medical supplies, and pet products, underpinned by its vast, integrated distribution network. Moreover, the company's software solutions, which are integral to their service offering, generate additional income through subscription fees and service upgrades. This ability to cross-sell digital and physical products creates a cohesive ecosystem for veterinary professionals, ensuring that Covetrus not only meets day-to-day operational needs but also facilitates long-term growth and competitiveness for its customers. Their strategic positioning within the veterinary supply chain, coupled with a clear focus on enhancing clinical workflows, cements Covetrus's role as an indispensable ally in modern animal healthcare.
See Also
What is Covetrus Inc's Total Current Liabilities?
Total Current Liabilities
20.1B
USD
Based on the financial report for Dec 31, 2025, Covetrus Inc's Total Current Liabilities amounts to 20.1B USD.
What is Covetrus Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
5%
Over the last year, the Total Current Liabilities growth was 9%. The average annual Total Current Liabilities growth rates for Covetrus Inc have been -6% over the past three years , 8% over the past five years , and 5% over the past ten years .